SINT
Sintx Technologies, Inc.NASDAQHealthcare$2.52+0.40%ClosedMarket Cap: $7.0M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.40
P/S
6.89
EV/EBITDA
-0.63
DCF Value
$-8.17
FCF Yield
-124.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
-19.7%
Operating Margin
-1053.1%
Net Margin
-1678.1%
ROE
-400.1%
ROA
-179.7%
ROIC
-173.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $341.0K | -124.0% | $-2.3M | $-2.2M | $-0.50 | — |
| FY 2025 | $1.0M | -19.7% | $-10.7M | $-17.1M | $-6.16 | — |
| Q3 2025 | $208.0K | 44.7% | $-3.4M | $-10.3M | $-3.46 | — |
| Q2 2025 | $100.0K | 6.0% | $-2.7M | $-2.3M | $-0.91 | — |
| Q1 2025 | $369.0K | 33.3% | $-2.4M | $-2.3M | $-1.29 | — |
| Q4 2024 | $542.0K | 71.6% | $-1.7M | $-1.7M | $-1.26 | — |
| FY 2024 | $1.2M | 34.9% | $-14.0M | $-11.0M | $-15.19 | — |
| Q3 2024 | $367.0K | 42.8% | $-6.4M | $-6.2M | $-6.95 | — |
| Q2 2024 | $378.0K | 40.7% | $-2.7M | $-2.2M | $-3.16 | — |
| Q1 2024 | $309.0K | 27.8% | $-3.2M | $-886.0K | $-1.90 | — |
| Q4 2023 | $902.0K | 50.7% | $-2.7M | $-2.3M | $-6.04 | — |
| FY 2023 | $2.6M | 70.2% | $-13.4M | $-8.3M | $-19.42 | — |